Ketone reductase activity and reduced haloperidol/haloperidol ratios in haloperidol-treated schizophrenic patients
- 28 July 1995
- journal article
- Published by Elsevier in Psychiatry Research
- Vol. 57 (2) , 101-108
- https://doi.org/10.1016/0165-1781(95)02633-8
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Pronounced differences between native Chinese and Swedish populations in the polymorphic hydroxylations of debrisoquin and S-mephenytoinClinical Pharmacology & Therapeutics, 1992
- Reduced haloperidol: a factor in determining the therapeutic benefit of haloperidol treatment?Psychopharmacology, 1992
- Dose-dependent reduced haloperidol/haloperidol ratios in schizophrenic patientsPsychiatry Research, 1991
- Haloperidol kinetics and clinical responseSchizophrenia Research, 1991
- Recent Developments in Hepatic Drug OxidationClinical Pharmacokinetics, 1990
- Metabolites of haloperidol display preferential activity at σ receptors compared to dopamine D-2 receptorsEuropean Journal of Pharmacology, 1990
- Pharmacokinetics of HaloperidolClinical Pharmacokinetics, 1989
- Haloperidol reduction can be assayed in human red blood cellsCanadian Journal of Physiology and Pharmacology, 1989
- Haloperidol and reduced haloperidol plasma levels in Chinese vs. non-Chinese psychiatric patientsPsychiatry Research, 1989
- Reduced haloperidol and haloperidol: Effects on homovanillic acid in caudate and prefrontal cortexBiological Psychiatry, 1987